Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.
Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.
复制标题
DOI:
10.1038/tpj.2014.27
复制
发表时间:
2014-12
期刊:
影响因子:
--
通讯作者:
O'Donnell PH
中科院分区:
文献类型:
--
作者:
Fang H;Liu X;Ramírez J;Choudhury N;Kubo M;Im HK;Konkashbaev A;Cox NJ;Ratain MJ;Nakamura Y;O'Donnell PH
Cytochrome P450 2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6, or CYP2D6), a highly polymorphic drug metabolizing enzyme, is involved in the metabolism of one quarter of the most commonly prescribed medications. Here, we have applied multiple genotyping methods and Sanger sequencing to assign precise and reproducible CYP2D6 genotypes, including copy numbers, for 48 HapMap samples. Furthermore, by analyzing a set of 50 human liver microsomes using endoxifen formation from N-desmethyl-tamoxifen as the phenotype of interest, we observed a significant positive correlation between CYP2D6 genotype-assigned activity score and endoxifen formation rate (rs = 0.68 by Rank correlation test, P = 5.3 ×10−8), which corroborated the genotype-phenotype prediction derived from our genotyping methodologies. In the future, these 48 publicly available HapMap samples characterized by multiple substantiated CYP2D6 genotyping platforms could serve as a reference resource for assay development, validation, quality control, and proficiency testing for other CYP2D6 genotyping projects, and for programs pursuing clinical pharmacogenomic testing implementation.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
6.7
作者:
Crews, K. R.;Gaedigk, A.;Skaar, T. C.
通讯作者:
Skaar, T. C.
影响因子:
2.8
作者:
Gaedigk, Andrea
通讯作者:
Gaedigk, Andrea
影响因子:
2.1
作者:
Qian, Jian-Chang;Xu, Xin-Min;Cai, Jian-Ping
通讯作者:
Cai, Jian-Ping
影响因子:
9.3
作者:
Hosono, Naoya;Kato, Mamoru;Kubo, Michiaki
通讯作者:
Kubo, Michiaki